Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Cancer Cell
|
October 6, 2009
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target
Dharminder Chauhan, Ajita V Singh, Mohan Brahmandam, et al.
Blood Cancer Journal
|
February 27, 2023
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JACC. Cardiovascular Imaging
|
September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Dominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
Prognostic Value of Left Ventricular <sup>18</sup> F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
Olivier F Clerc, Yesh Datar, Sarah Am Cuddy, et al.
JACC. Cardiovascular Imaging
|
December 19, 2021
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy
Sarah A M Cuddy, Michael Jerosch-Herold, Rodney H Falk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
Ashutosh D Wechalekar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
JACC. Cardiovascular Imaging
|
July 13, 2024
Prognostic Value of Left Ventricular <sup>18</sup>F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
Olivier F Clerc, Yesh Datar, Sarah A M Cuddy, et al.
Kidney International Reports
|
June 8, 2026
Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant
Cristian V Riella, Dan A Colombo, Helmut G Rennke, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Cancer Cell
|
October 6, 2009
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target
Dharminder Chauhan, Ajita V Singh, Mohan Brahmandam, et al.
Blood Cancer Journal
|
February 27, 2023
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
Maria Moscvin, Christine Ivy Liacos, Tianzeng Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
JACC. Cardiovascular Imaging
|
September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Dominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
Prognostic Value of Left Ventricular <sup>18</sup> F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
Olivier F Clerc, Yesh Datar, Sarah Am Cuddy, et al.
JACC. Cardiovascular Imaging
|
December 19, 2021
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy
Sarah A M Cuddy, Michael Jerosch-Herold, Rodney H Falk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
Ashutosh D Wechalekar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
JACC. Cardiovascular Imaging
|
July 13, 2024
Prognostic Value of Left Ventricular <sup>18</sup>F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
Olivier F Clerc, Yesh Datar, Sarah A M Cuddy, et al.
Kidney International Reports
|
June 8, 2026
Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant
Cristian V Riella, Dan A Colombo, Helmut G Rennke, et al.
Page
of 10